Interventional Cardiology Market Size, Share & COVID19 Impact Analysis | United States | 2020–2026 | MedSuite | Includes: Coronary Stent Market, Coronary Balloon Catheter Market, Introducer Sheath Market, and 12 more
- Year: 2020
- Scope: 10 Years
- Region: United States
- Pages: 442
- Published Date: 09/29/2020
- Type: MedSuite
In 2020, the U.S. interventional cardiology device market size was valued at approximately $3.2 billion, with over 965,000 PCI procedures performed every year. The market size is expected to increase at a compound annual growth rate (CAGR) of 3.6% to reach $4.1 billion by 2026.
Throughout this medical market research, we analyzed 43 interventional cardiology device companies across the United States and used our comprehensive methodology to understand the market sizes, unit sales, company market shares, and to create accurate forecasts.
While this MedSuite report contains all of the US Interventional Cardiology Device market analysis and data, each of the market segments is also available as stand-alone MedCore reports. This allows you to get access to only the market research that you need.
DATA TYPES INCLUDED
- Unit Sales, Average Selling Prices, Market Value & Growth Trends
- Procedure Volumes for the Interventional Cardiology Devices
- Market Forecasts Until 2026, and Historical Data to 2016
- Competitive Analysis with Market Shares for Each Segment
- Market Drivers & Limiters for Each Interventional Cardiology Device Market
- Recent Mergers & Acquisitions
- COVID19 Impact on the Interventional Cardiology Device Market in the US
- Disease Overviews and Demographic Information
- Company Profiles, Product Portfolios and SWOT for Top Competitors
Interventional Cardiology Market Insights
Similar to other medical device markets, the interventional cardiology market has been experiencing a period of consolidation in recent years. Large competitors are either entering the overall market or expanding their reach by entering new segments through strategic mergers and acquisitions. A recent survey shows that one-quarter of healthcare professionals believe that healthcare industry consolidation was the most important trend in 2019. The second-most important healthcare trend is consumerism, where patients are thinking like consumers who seek lower costs and convenience from their care providers.
The PCI procedural volume has stabilized over the last several years and is expected to grow over the forecast period. Procedure growth exhibits a positive effect on the associated device markets, such as stents, balloon catheters, interventional catheters and guidewires, and various other devices required per procedure. The angiography procedural volume is also expected to remain stable over the forecast period, outside of COVID-19-related fluctuations. One of the factors driving procedure growth is the increased focus on complex PCI patients. In particular, the development of specialized devices, like hemostasis valves and extension guide catheters, enables complex cases to be treated through minimally invasive treatments rather than coronary artery bypass graft (CABG) or medication.
COVID19 Impact on the Interventional Cardiology Market in the US
In March 2020, the Centers for Medicare & Medicaid Services (CMS) recommended that doctors and health centers postpone non-essential elective surgeries and medical procedures to conserve medical resources for COVID-19-related and life-threatening cases. Since this announcement, cardiovascular procedures were severely impacted. While percutaneous coronary intervention (PCI) procedures are still considered urgent in treating acute myocardial infarctions (MI), or heart attacks, only a small proportion of PCI procedures performed on patients were for these life-threatening conditions.
The rest of the PCI procedures are categorized as “elective procedures” and were avoided or deferred during the pandemic. Across the U.S., hospitals saw a decline in cardiovascular procedures performed. Overall, the US interventional cardiology market size is expected to reach its pre-COVID19 level in late 2021 / early 2022.
Interventional Cardiology Market Share Insight
By 2020, Boston Scientific maintained the leading position in the U.S. interventional cardiology market. The company is active across almost all segments, and held a leading position in several segments, including the coronary stent, coronary balloon catheter, and coronary embolic protection device markets.
Abbott maintained its second-leading position in the US interventional cardiology device market, benefitting from a strong presence across most market segments. The company recently expanded its presence in the market, mainly through its acquisition of St. Jude Medical in 2017.
The third leading competitor in the US market was Medtronic. The company has been aggressively expanding its presence in both the coronary and peripheral interventional markets. The company is able to implement a bundling strategy to leverage its position in the competitive landscape.
Detailed Market Segmentation
- Procedure Volumes for Interventional Cardiology Market– MedPro – Using a number of databases, internal and external, we’re able to provide you with the volume of interventional cardiology procedures being performed, including Angiography, Angioplasty/PCI, Coronary Atherectomy, and Catheterization procedures.
- Coronary Stent Market – MedCore – The market is further broken down into segments by:
- Device Type: Bare-Metal Stents, Drug-Eluting Stents, Covered Stents, and Bifurcated Stents;
- Units Size: Length and Diameter.
- Coronary Balloon Catheter Market – MedCore – The market is also further segmented by:
- Device Type: PTCA Balloon and Specialty Balloon (Cutting/Scoring);
- Classification: Compliant, Semi-Compliant, and Non-Compliant;
- Indication: Pre-Dilation & Stent Placement, and Post-Dilation.
- Introducer Sheath Market – MedCore – The chapter contains the market analysis which is categorized by:
- Device Type: Standard Introducer and Micro-Introducer Sheaths;
- Approach: Femoral and Radial.
- Balloon-Inflation Device Market – MedCore – In-depth analysis of the Balloon-Inflation Device market.
- Interventional Coronary Catheter Market – MedCore – This market and its analysis is categorized into Guiding Catheters, Extension Guide Catheters, and Micro-Catheters.
- Interventional Coronary Guidewire Market – MedCore – In-depth analysis of the Interventional Coronary Guidewire market.
- Coronary Embolic Protection Device Market – MedCore – In-depth analysis of the Coronary Embolic Protection Device market.
- Coronary Atherectomy Device Market – MedCore – The market is further broken down into Mechanical Atherectomy and Laser Atherectomy devices.
- Coronary Thrombectomy Market – MedCore – In-depth analysis of the Coronary Thrombectomy market.
- Coronary Chronic Total Occlusion (CTO) System Market – MedCore – This market consists of the segments for the CTO Guidewires, CTO Catheters, and CTO Devices.
- Coronary Vascular Closure Device (VCD) Market – MedCore – The market analysis includes the segments, such as Invasive and Non-Invasive VCDs (Topical Hemostats/Radial Compression Bands/Femoral Compression Bands).
- Diagnostic Coronary Catheter & Guidewire Market – MedCore – The chapter takes a closer look at the different market segments, including Diagnostic Catheter, Diagnostic Guidewire, and FFR Guidewire markets.
- Coronary Intravascular Ultrasound (IVUS) Market – MedCore – The market is further broken down into segments based on the Device Type into IVUS Catheters and IVUS Consoles.
- Coronary Optical Coherency Tomography Market – MedCore – In-depth analysis of the Coronary Optical Coherency Tomography market.
- Hemostasis Valve Market – MedCore – In-depth analysis of the Hemostasis Valve market.
DON’T SEE THE SEGMENT OR DATA YOU NEED?
Feel free to contact us or send a request by pressing one of the buttons below.
TABLE OF CONTENTS THE US INTERVENTIONAL CARDIOLOGY MARKET REPORT SUITETABLE OF CONTENTS ILIST OF FIGURES XIVLIST OF CHARTS XXIIIEXECUTIVE SUMMARY 1U.S. INTERVENTIONAL CARDIOLOGY DEVICE MARKET OVERVIEW 1COMPETITIVE ANALYSIS 5MARKET TRENDS 8MARKET DEVELOPMENTS 11PROCEDURE NUMBERS 12PROCEDURE CODES INVESTIGATED 13MARKETS INCLUDED 14KEY REPORT UPDATES 16VERSION HISTORY 16RESEARCH METHODOLOGY 17Step 1: Project Initiation & Team Selection 17Step 2: Prepare Data Systems and Perform Secondary Research 20Step 3: Preparation for Interviews & Questionnaire Design 22Step 4: Performing Primary Research 23Step 5: Research Analysis: Establishing Baseline Estimates 25Step 6: Market Forecast and Analysis 26Step 7: Identify Strategic Opportunities 28Step 8: Final Review and Market Release 29Step 9: Customer Feedback and Market Monitoring 30
DISEASE OVERVIEW2.1 BASIC ANATOMY 312.2 DISEASE TREATMENTS AND DIAGNOSTICS 332.2.1 General Diagnostics 332.2.2 Coronary Artery Disease (CAD) 332.2.3 Myocardial Infarction (MI) 342.2.4 Angina Pectoris 352.3 PATIENT DEMOGRAPHICS 362.3.1 General Statistics 36
PRODUCT ASSESSMENT3.1 INTRODUCTION 383.2 PRODUCT PORTFOLIOS 383.2.1 Coronary Stent Market 383.2.2 Coronary Balloon Catheter Market 413.2.3 Balloon-Inflation Device Market 443.2.4 Interventional Coronary Catheter Market 453.2.5 Interventional Coronary Guidewire Market 483.2.6 Coronary Embolic Protection Device Market 522.214.171.124 Saphenous Vein Grafts 5126.96.36.199 Protection Mechanism 5188.8.131.52.1 Filter Basket 5184.108.40.206.2 Distal Balloon Occlusion 523.2.7 Coronary Atherectomy Device Market 5220.127.116.11 Laser Atherectomy 518.104.22.168 Directional Coronary Atherectomy (DCA) 522.214.171.124 Mechanical Atherectomy 543.2.8 Coronary Thrombectomy Device Market 553.2.9 Coronary Chronic Total Occlusion Device Market 563.2.10 Coronary Introducer Sheath Market 5126.96.36.199 Femoral Approach 5188.8.131.52 Radial/Brachial Approach 593.2.11 Coronary Vascular Closure Device Market 613.2.12 Diagnostic Coronary Catheter & Guidewire 633.2.13 Coronary Intravascular Ultrasound Market 653.2.14 Optical Coherence Tomography Market 673.2.15 Hemostasis Valve Market 693.3 REGULATORY ISSUES AND RECALLS 703.3.1 Abbott 703.3.1.1 Coronary Stent 703.3.1.2 Coronary Balloon Catheter 703.3.1.3 Introducer Sheath 7184.108.40.206 Coronary Vascular Closure Device 723.3.2 Boston Scientific 7220.127.116.11 Coronary Stent 718.104.22.168 Coronary Balloon Catheter 722.214.171.124 Balloon-Inflation Device 7126.96.36.199 Interventional Coronary Catheter 7188.8.131.52 Interventional Coronary Guidewire 7184.108.40.206 Coronary Thrombectomy 763.3.3 Cardinal Health 7220.127.116.11 Coronary Stent 773.3.4 Medtronic 718.104.22.168 Coronary Stent 722.214.171.124 Introducer Sheath 7126.96.36.199 Coronary Balloon Catheter 7188.8.131.52 Interventional Coronary Catheter 793.3.5 Merit Medical Systems 8184.108.40.206 Introducer Sheath 813.3.7 Terumo 8220.127.116.11 Interventional Coronary Catheter 818.104.22.168 Introducer Sheath 822.214.171.124 Coronary Vascular Closure Device 843.4 CLINICAL TRIALS 853.4.1 Coronary Stent 8126.96.36.199 Abbott 8188.8.131.52 Boston Scientific 8184.108.40.206 Medtronic 883.4.2 Coronary Balloon Catheter 9220.127.116.11 Boston Scientific 918.104.22.168 Medtronic 923.4.3 Balloon Inflation Device 922.214.171.124 Central Arkansas Veterans Healthcare System 9126.96.36.199 Guy’s and St Thomas’ NHS Foundation Trust 933.4.4 Interventional Coronary Catheter 9188.8.131.52 Medtronic 9184.108.40.206 Philips 963.4.5 Coronary Embolic Protection Device 9220.127.116.11 Icahan School of Medicine at Mount Sinai 918.104.22.168 Javelin Medical 922.214.171.124 Keystone Heart 9126.96.36.199 Microvention-Terumo, Inc 993.4.6 Coronary Atherectomy Device 1003.4.6.1 Segeberger Kliniken GmbH 1003.4.6.2 Spectranetics Corporation 1003.4.7 Coronary Vascular Closure Device 1013.4.7.1 Cordis Corporation 1013.4.7.2 Medtronic 1023.4.7.3 Terumo Medical Corporation 1023.4.8 Coronary Intravascular Ultrasound 1033.4.8.1 Aarhhus University Hospital Skejby 1033.4.8.2 European Cardiovascular Research Institute 1043.4.9 Coronary Optical Coherence Tomography 1053.4.9.1 Columbia University 105
U.S. INTERVENTIONAL CARDIOLOGY DEVICE MARKET OVERVIEW4.1 INTRODUCTION 1064.1.1 Population at Risk 1064.2 MARKET OVERVIEW 1084.3 TREND ANALYSIS BY SEGMENT 1144.4 DRIVERS AND LIMITERS 1194.4.1 Market Drivers 1194.4.2 Market Limiters 1204.5 COMPETITIVE MARKET SHARE ANALYSIS 1224.6 MERGERS & ACQUISITIONS 1304.7 COMPANY PROFILES 1324.7.1 Abbott 1324.7.2 Asahi Intecc 1344.7.3 Boston Scientific 1354.7.4 Cardinal Health 13188.8.131.52 Cordis (Cardinal Health) 1374.7.5 Cardiovascular Systems Inc. 1384.7.6 Cook Medical 1394.7.7 Medtronic 1404.7.8 Merit Medical Systems 1424.7.9 Penumbra 1434.7.10 Philips 1444.7.11 Teleflex 1464.7.12 Terumo 1484.8 SWOT ANALYSIS 1504.8.1 Abbott 1514.8.2 Asahi Intecc 1524.8.3 Boston Scientific 1534.8.4 Cardinal Health 1544.8.5 Cardiovascular Systems Inc. 1554.8.6 Cook Medical 1564.8.7 Medtronic 1574.8.8 Merit Medical Systems 1584.8.9 Penumbra 1594.8.10 Philips 1604.8.11 Teleflex 1614.8.12 Terumo 162
IMPACT OF COVID-19 ON THE U.S. INTERVENTIONAL CARDIOLOGY DEVICE MARKET5.1 INTRODUCTION 1635.1.1 Treatable Population and the COVID-19 Virus 1645.1.2 Market Specifics 1645.1.3 United States COVID-19 Impact 1655.2 MULTI-SCENARIO ANALYSIS 16184.108.40.206 Best Case Scenario 16220.127.116.11 Base Case Scenario 1618.104.22.168 Worst Case Scenario 170
PROCEDURE NUMBERS6.1 INTRODUCTION 1736.2 PROCEDURES OVERVIEW 1746.2.1 Angiography Procedures 1722.214.171.124 Angiography Procedures by Approach 17126.96.36.199 Angiography Procedures by Setting 1806.2.2 Angioplasty/PCI Procedures 18188.8.131.52 Angioplasty/PCI Procedures by Approach 18184.108.40.206 Angioplasty/PCI Procedures by Modality 18220.127.116.11 Angioplasty/PCI Procedures by Setting 1818.104.22.168 Angioplasty/PCI Procedures by Imaging Technique 1906.2.3 Coronary Atherectomy Procedures 1916.2.4 Catheterization Procedures 193
CORONARY STENT MARKET7.1 INTRODUCTION 1957.2 MARKET OVERVIEW 1977.3 MARKET ANALYSIS AND FORECAST 2017.3.1 Total Coronary Stent Market 2017.3.2 Bare-Metal Stent Market 2037.3.3 Drug-Eluting Stent Market 2057.3.4 Covered Stent Market 2077.3.5 Bifurcated Stent Market 2097.4 UNIT ANALYSIS 2117.4.1 Coronary Stent Units Sold by Diameter 2117.4.2 Coronary Stent Units Sold by Length 2127.5 DRIVERS AND LIMITERS 2137.5.1 Market Drivers 2137.5.2 Market Limiters 2137.6 COMPETITIVE MARKET SHARE ANALYSIS 216
CORONARY BALLOON CATHETER MARKET8.1 INTRODUCTION 2218.2 MARKET OVERVIEW 2228.3 MARKET ANALYSIS AND FORECAST 2258.3.1 Total Coronary Balloon Catheter Market 2258.3.2 PTCA Balloon Catheter Market 2278.3.3 Total Specialty Balloon Catheter Market 2222.214.171.124 Cutting Balloon Catheter Market 23126.96.36.199 Scoring Balloon Catheter Market 2348.4 UNIT ANALYSIS 2368.4.1 Coronary Balloon Catheter Units Sold by Classification 2368.4.2 Coronary Balloon Catheter Units Sold by Indication 2378.5 DRIVERS AND LIMITERS 2388.5.1 Market Drivers 2388.5.2 Market Limiters 2388.6 COMPETITIVE MARKET SHARE ANALYSIS 241
BALLOON-INFLATION DEVICE MARKET9.1 INTRODUCTION 2459.2 MARKET ANALYSIS AND FORECAST 2469.3 DRIVERS AND LIMITERS 2489.3.1 Market Drivers 2489.3.2 Market Limiters 2489.4 COMPETITIVE MARKET SHARE ANALYSIS 251
INTERVENTIONAL CORONARY CATHETER MARKET10.1 INTRODUCTION 25410.2 MARKET OVERVIEW 25510.3 MARKET ANALYSIS AND FORECAST 25810.3.1 Total Interventional Coronary Catheter Market 25810.3.2 Guiding Catheter Market 26010.3.3 Extension Guide Catheter Market 26210.3.4 Micro-Catheter Market 26410.4 DRIVERS AND LIMITERS 26610.4.1 Market Drivers 26610.4.2 Market Limiters 26610.5 COMPETITIVE MARKET SHARE ANALYSIS 268
INTERVENTIONAL CORONARY GUIDEWIRE MARKET11.1 INTRODUCTION 27311.1.1 Device Construction 27311.2 MARKET ANALYSIS AND FORECAST 27411.3 DRIVERS AND LIMITERS 27611.3.1 Market Drivers 27611.3.2 Market Limiters 27611.4 COMPETITIVE MARKET SHARE ANALYSIS 278
CORONARY EMBOLIC PROTECTION DEVICE MARKET12.1 INTRODUCTION 28112.1.1 Saphenous Vein Grafts 28112.1.2 Protection Mechanism 28188.8.131.52 Filter Basket 28184.108.40.206 Distal Balloon Occlusion 28212.2 MARKET ANALYSIS AND FORECAST 28312.3 DRIVERS AND LIMITERS 28512.3.1 Market Drivers 28512.3.2 Market Limiters 28512.4 COMPETITIVE MARKET SHARE ANALYSIS 287For a Full Table of Contents, please contact iData.
iData’s 9-Step Research MethodologyOur reports follow an in-depth 9-step methodology which focuses on the following research systems:
- Original primary research that consists of the most up-to-date market data
- Strong foundation of quantitative and qualitative research
- Focused on the needs and strategic challenges of the industry participants
Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.
Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.
Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.
Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.
Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.
Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.
Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.
Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.
Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.